PRECISEU Best Practice Recognition in the Field of Advanced Therapy Medicinal Products

The PRECISEU project invites stakeholders to participate in the second edition of the PRECISEU Best Practice Recognition. The program honors outstanding achievements, innovative approaches, and exemplary concepts in use of health data for public health improvement or healthcare delivery and are innovative in the fields of Advanced Therapy Medicinal Products (ATPMs).

© bongkarn – stock.adobe.com

The Recognition offers the opportunity to present proven methods, connect with valuable contacts, and engage with other leading experts in the field. Additionally, recognised participants will receive official recognition and be highlighted in various publications and on the PRECISEU platform.

Categories for the second edition of the PRECISEU Best Practice Recognition:

  • IMPACT: Collaborating organisations that can demonstrate significant impact in healthcare via a transformative academic/business partnership supported by evidence-based results.
  • INNOVATION: Organisations that are revolutionising patient care in the field of ATMPs through breakthrough innovations, leveraging patient data to drive transformative solutions.
  • EXCELLENCE: Organisations of health data excellence with respect to best accessibility, interoperability, safety, data stratification, quality standards for raw data input, and inclusivity when utilising patient data for personalised medicine.
  • CULTURE: Organisations that have developed best patient involvement and public engagement and serve as an example of best practices in communication for cultural impact on society in health data use.

The call for applications is open for submission until 01 March 2026.